Evidence map›Paper›PMID 36996041›Full record

ArticlePLoS pathogens2023

The anti-immune dengue subgenomic flaviviral RNA is present in vesicles in mosquito saliva and is associated with increased infectivity.

Shih-Chia Yeh, Tania Strilets, Wei-Lian Tan, David Castillo, Hacène Medkour, Félix Rey-Cadilhac, Idalba M Serrato-Pomar, Florian Rachenne, Avisha Chowdhury, Vanessa Chuo and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. YBX1 regulates RNA polymerase III transcripts to prevent inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Dengue virus harnesses mosquito Syntenin to load and secrete viral RNA into salivary exosomes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Cellular Biology: Virus-Host Interactions and RNA Structure and Function.Current topics in microbiology and immunology · 2026
    Review
  11. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 4 countries.

Shih-Chia YehProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Tania StriletsDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Wei-Lian TanProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
David CastilloCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Hacène MedkourMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Félix Rey-CadilhacMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Idalba M Serrato-PomarMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Florian RachenneMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Avisha ChowdhuryDepartment of Biological Sciences, National University of Singapore, Singapore.
Vanessa ChuoProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Sasha R AzarDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Moirangthem Kiran SinghDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Rodolphe HamelMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Dorothée MisséMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
R Manjunatha KiniDepartment of Biological Sciences, National University of Singapore, Singapore.
Linda J KenneyDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Nikos VasilakisDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Marc A Marti-RenomCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Guy NirDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Julien PomponProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Mariano A Garcia-BlancoProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID 0000-0001-8538-1997
Centre National de la Recherche Scientifique · FRThe University of Texas Medical Branch at Galveston · USDuke-NUS Medical School · SGNational University of Singapore · SGCentre for Genomic Regulation · ESInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus DiseaseP01AI150585 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BUKREYEV, ALEXANDER · 2021 to 2025
$11.3M
Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Kathryn Alyce Hanley, MAURICIO Lacerda NOGUEIRA · 2020 to 2026
$9.8M
NIAID NIH HHS P01 AI150585
6 · The paper itself

Abstract

Mosquito transmission of dengue viruses to humans starts with infection of skin resident cells at the biting site. There is great interest in identifying transmission-enhancing factors in mosquito saliva in order to counteract them. Here we report the discovery of high levels of the anti-immune subgenomic flaviviral RNA (sfRNA) in dengue virus 2-infected mosquito saliva. We established that sfRNA is present in saliva using three different methods: northern blot, RT-qPCR and RNA sequencing. We next show that salivary sfRNA is protected in detergent-sensitive compartments, likely extracellular vesicles. In support of this hypothesis, we visualized viral RNAs in vesicles in mosquito saliva and noted a marked enrichment of signal from 3'UTR sequences, which is consistent with the presence of sfRNA. Furthermore, we show that incubation with mosquito saliva containing higher sfRNA levels results in higher virus infectivity in a human hepatoma cell line and human primary dermal fibroblasts. Transfection of 3'UTR RNA prior to DENV2 infection inhibited type I and III interferon induction and signaling, and enhanced viral replication. Therefore, we posit that sfRNA present in salivary extracellular vesicles is delivered to cells at the biting site to inhibit innate immunity and enhance dengue virus transmission.

Indexed as

AedesCulicidaeDengueFlavivirus3' Untranslated RegionsAnimalsHumansRNA, ViralSalivaSubgenomic RNAVirus Replication3' Untranslated RegionsRNA, ViralSubgenomic RNA

Identifiers

PMID36996041
PMCPMC10062553
OpenAlexW4361268628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.